ID: ALA5286196

Max Phase: Preclinical

Molecular Formula: C21H19NO3

Molecular Weight: 333.39

Associated Items:

Representations

Canonical SMILES:  COc1ccc(-c2ccc(CNc3cccc(C(=O)O)c3)cc2)cc1

Standard InChI:  InChI=1S/C21H19NO3/c1-25-20-11-9-17(10-12-20)16-7-5-15(6-8-16)14-22-19-4-2-3-18(13-19)21(23)24/h2-13,22H,14H2,1H3,(H,23,24)

Standard InChI Key:  GBHFOJDBNYLHDA-UHFFFAOYSA-N

Associated Targets(Human)

Peroxisome proliferator-activated receptor alpha 9197 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 333.39Molecular Weight (Monoisotopic): 333.1365AlogP: 4.67#Rotatable Bonds: 6
Polar Surface Area: 58.56Molecular Species: ACIDHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 4.82CX Basic pKa: 3.38CX LogP: 4.12CX LogD: 1.73
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.69Np Likeness Score: -0.71

References

1. Lee JJ, Hu Z, Wang YA, Nath D, Liang W, Cui Y, Ma JX, Duerfeldt AS..  (2023)  Design, Synthesis, and Structure-Activity Relationships of Biaryl Anilines as Subtype-Selective PPAR-alpha Agonists.,  14  (6): [PMID:37312852] [10.1021/acsmedchemlett.3c00056]

Source